Importer of Controlled Substances Application: Research Triangle Institute, 20734-20738 [2021-08166]
Download as PDF
<![CDATA[
20734
Federal Register / Vol. 86, No. 75 / Wednesday, April 21, 2021 / Notices
Sheran Arden Yeates, M.D., 71 FR
39130, 39131 (2006); Dominick A. Ricci,
M.D., 58 FR 51104, 51105 (1993); Bobby
Watts, M.D., 53 FR 11919, 11920 (1988);
Frederick Marsh Blanton, 43 FR at
27617.
Under the Virginia Drug Control Act,
a practitioner ‘‘shall only prescribe,
dispense, or administer controlled
substances in good faith for medicinal
or therapeutic purposes within the
course of his professional practice.’’ Va.
Code 54.1–3408. The Virginia Drug
Control Act also defines a
‘‘practitioner,’’ as ‘‘a physician . . .
licensed, registered, or otherwise
permitted to distribute, dispense,
prescribe and administer, or conduct
research with respect to a controlled
substance in the course of professional
practice or research in the
Commonwealth.’’ Va. Code 54.1–3401.
Further, under Virginia state law, a
‘‘physician’’ is defined as ‘‘a person
licensed to practice medicine in the
Commonwealth of Virginia or in the
jurisdiction where the health care is to
be rendered or withheld.’’ Va. Code
54.1–2981; see also: Va. Code 54.1–2902
(‘‘It shall be unlawful for any person to
practice medicine . . . in the
Commonwealth without a valid
unrevoked license issued by the Board
of Medicine.’’).
Here, the undisputed evidence in the
record is that Registrant currently lacks
authority to practice medicine in
Virginia. As already discussed, a
physician must be a licensed
practitioner to dispense a controlled
substance in Virginia. Thus, because
Registrant lacks authority to practice
medicine in Virginia and, therefore, is
not authorized to handle controlled
substances in Virginia, Registrant is not
eligible to maintain a DEA registration.
Accordingly, I will order that
Registrant’s DEA registration be
revoked.
Order
Pursuant to 28 CFR 0.100(b) and the
authority vested in me by 21 U.S.C.
824(a), I hereby revoke DEA Certificate
of Registration No. AP1844287 issued to
Javaid A. Perwaiz. Further, pursuant to
28 CFR 0.100(b) and the authority
vested in me by 21 U.S.C. 823(f), I
hereby deny any pending application of
Javaid A. Perwaiz to renew or modify
this registration, as well as any other
pending application of Javaid A.
Perwaiz, for additional registration in
Virginia. This Order is effective May 21,
2021.
D. Christopher Evans,
Acting Administrator.
[FR Doc. 2021–08173 Filed 4–20–21; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–816]
Importer of Controlled Substances
Application: Research Triangle
Institute
Drug Enforcement
Administration, Department of Justice.
ACTION: Notice of application.
AGENCY:
Research Triangle Institute
has applied to be registered as an
SUMMARY:
importer of basic class(es) of controlled
substance(s). Refer to SUPPLEMENTARY
INFORMATION listed below for further
drug information.
Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before May 21, 2021. Such persons
may also file a written request for a
hearing on the application on or before
May 21, 2021.
DATES:
Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing must
be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All requests for a
hearing should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/OALJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/DPW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
ADDRESSES:
In
accordance with 21 CFR 1301.34(a), this
is notice that on March 18, 2021,
Research Triangle Institute, 3040 East
Cornwallis Road, Hermann Building,
Room 106, Research Triangle Park,
North Carolina 22709–0000, applied to
be registered as an importer of the
following basic class(es) of controlled
substance(s):
SUPPLEMENTARY INFORMATION:
Drug
code
khammond on DSKJM1Z7X2PROD with NOTICES
Controlled substance
3-Fluoro-N-methylcathinone (3–FMC) .....................................................................................................................................
Cathinone ................................................................................................................................................................................
Methcathinone .........................................................................................................................................................................
4-Fluoro-N-methylcathinone (4–FMC) .....................................................................................................................................
Pentedrone (a-methylaminovalerophenone) ...........................................................................................................................
Mephedrone (4-Methyl-N-methylcathinone) ............................................................................................................................
4-Methyl-N-ethylcathinone (4–MEC) .......................................................................................................................................
Naphyrone ...............................................................................................................................................................................
N-Ethylamphetamine ...............................................................................................................................................................
N,N-Dimethylamphetamine ......................................................................................................................................................
Fenethylline .............................................................................................................................................................................
Aminorex ..................................................................................................................................................................................
4-Methylaminorex (cis isomer) ................................................................................................................................................
Gamma Hydroxybutyric Acid ...................................................................................................................................................
Methaqualone ..........................................................................................................................................................................
Mecloqualone ..........................................................................................................................................................................
JWH–250 (1-Pentyl-3-(2-methoxyphenylacetyl) indole) ..........................................................................................................
SR–18 (Also known as RCS–8) (1-Cyclohexylethyl-3-(2-methoxyphenylacetyl) indole) ........................................................
ADB–FUBINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide) .....................
5-Fluoro-UR–144 and XLR11 [1-(5-Fluoro-pentyl)1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone ........................
AB–FUBINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide) .............................
FUB–144 (1-(4-fluorobenzyl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone) .......................................................
JWH–019 (1-Hexyl-3-(1-naphthoyl)indole) ..............................................................................................................................
MDMB–FUBINACA (Methyl 2-(1-(4-fluorobenzyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate) ..............................
VerDate Sep<11>2014
18:12 Apr 20, 2021
Jkt 253001
PO 00000
Frm 00083
Fmt 4703
Sfmt 4703
E:\FR\FM\21APN1.SGM
21APN1
1233
1235
1237
1238
1246
1248
1249
1258
1475
1480
1503
1585
1590
2010
2565
2572
6250
7008
7010
7011
7012
7014
7019
7020
Schedule
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
20735
Federal Register / Vol. 86, No. 75 / Wednesday, April 21, 2021 / Notices
Drug
code
khammond on DSKJM1Z7X2PROD with NOTICES
Controlled substance
FUB–AMB, MMB- FUBINACA, AMB–FUBINACA (2-(1-(4-fluorobenzyl)-1Hindazole-3-carboxamido)-3-methylbutanoate) ..
AB–PINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide) .................................................
THJ–2201 ([1-(5-fluoropentyl)-1H-indazol-3-yl](naphthalen-1-yl)methanone) .........................................................................
5F–AB–PINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(5-fluropentyl)-1H-indazole-3-carboximide) ................................
AB–CHMINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide) .......................
MAB–CHMINACA (N-(1-amino-3,3dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide) ................
5F–AMB (Methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3-methylbutanoate) ......................................................
5F–ADB, 5F–MDMB–PINACA (Methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate) ..............
ADB–PINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide) .........................................
5F–EDMB–PINACA (ethyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate) .................................
5F–MDMB–PICA (methyl 2-(1-(5-fluoropentyl)-1H-indole-3-carboxamido)-3,3-dimethylbutanoate) ......................................
MDMB–CHMICA, MMB–CHMINACA (Methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3,3-dimethylbutanoate) ..
MMB–CHMICA, AMB–CHMICA (methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3-methylbutanoate) ................
FUB–AKB48, FUB–APINACA, AKB48 N-(4–FLUOROBENZYL) (N-(adamantan-1-yl)-1-(4-fluorobenzyl)-1H-indazole-3carboximide).
APINACA and AKB48 (N-(1-Adamantyl)-1-pentyl-1H-indazole-3-carboxamide) ....................................................................
5F–APINACA, 5F–AKB48 (N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide) ..........................................
JWH–081 (1-Pentyl-3-(1-(4-methoxynaphthoyl) indole) ..........................................................................................................
5F–CUMYL–PINACA, 5GT–25 (1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide) ............................
5F–CUMYL–P7AICA (1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-pyrrolo[2,3-b]pyridine-3-carboxamide) .......................
4–CN–CUML–BUTINACA, 4-cyano-CUMYL–BUTINACA, 4–CN–CUMYL BINACA, CUMYL–4CN–BINACA, SGT–78 (1(4-cyanobutyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide).
SR–19 (Also known as RCS–4) (1-Pentyl-3-[(4-methoxy)-benzoyl] indole) ...........................................................................
JWH–018 (also known as AM678) (1-Pentyl-3-(1-naphthoyl)indole) ......................................................................................
JWH–122 (1-Pentyl-3-(4-methyl-1-naphthoyl) indole) .............................................................................................................
UR–144 (1-Pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone .........................................................................
JWH–073 (1-Butyl-3-(1-naphthoyl)indole) ...............................................................................................................................
JWH–200 (1-[2-(4-Morpholinyl)ethyl]-3-(1-naphthoyl)indole) ..................................................................................................
AM2201 (1-(5-Fluoropentyl)-3-(1-naphthoyl) indole) ...............................................................................................................
JWH–203 (1-Pentyl-3-(2-chlorophenylacetyl) indole) ..............................................................................................................
NM2201, CBL2201 (Naphthalen-1-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate ..................................................................
PB–22 (Quinolin-8-yl 1-pentyl-1H-indole-3-carboxylate) .........................................................................................................
5F–PB–22 (Quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate) ....................................................................................
4-Methyl-alpha-ethylaminopentiophenone (4–MEAP) .............................................................................................................
N-Ethylhexedrone ....................................................................................................................................................................
Alpha-ethyltryptamine ..............................................................................................................................................................
Ibogaine ...................................................................................................................................................................................
CP–47,497 (5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl-phenol) ........................................................................
CP–47,497 C8 Homologue (5-(1,1-Dimethyloctyl)-2-[(1R,3S)3-hydroxycyclohexyl-phenol) ..................................................
Lysergic acid diethylamide ......................................................................................................................................................
2C–T–7 (2,5-Dimethoxy-4-(n)-propylthiophenethylamine .......................................................................................................
Marihuana Extract ...................................................................................................................................................................
Parahexyl .................................................................................................................................................................................
Mescaline .................................................................................................................................................................................
2C–T–2 (2-(4-Ethylthio-2,5-dimethoxyphenyl) ethanamine ) ..................................................................................................
3,4,5-Trimethoxyamphetamine ................................................................................................................................................
4-Bromo-2,5-dimethoxyamphetamine .....................................................................................................................................
4-Bromo-2,5-dimethoxyphenethylamine ..................................................................................................................................
4-Methyl-2,5-dimethoxyamphetamine .....................................................................................................................................
2,5-Dimethoxyamphetamine ....................................................................................................................................................
JWH–398 (1-Pentyl-3-(4-chloro-1-naphthoyl) indole) ..............................................................................................................
2,5-Dimethoxy-4-ethylamphetamine ........................................................................................................................................
3,4-Methylenedioxyamphetamine ............................................................................................................................................
5-Methoxy-3,4-methylenedioxyamphetamine ..........................................................................................................................
N-Hydroxy-3,4-methylenedioxyamphetamine ..........................................................................................................................
3,4-Methylenedioxy-N-ethylamphetamine ...............................................................................................................................
3,4-Methylenedioxymethamphetamine ....................................................................................................................................
4-Methoxyamphetamine ..........................................................................................................................................................
Peyote ......................................................................................................................................................................................
5-Methoxy-N–N-dimethyltryptamine ........................................................................................................................................
Alpha-methyltryptamine ...........................................................................................................................................................
Bufotenine ................................................................................................................................................................................
Diethyltryptamine .....................................................................................................................................................................
Dimethyltryptamine ..................................................................................................................................................................
Psilocybin .................................................................................................................................................................................
Psilocyn ...................................................................................................................................................................................
5-Methoxy-N,N-diisopropyltryptamine .....................................................................................................................................
4-Chloro-alpha-pyrrolidinovalerophenone (4-chloro-a-PVP ) ..................................................................................................
4-Methyl-alpha-pyrrolidinohexiophenone (MPHP) ...................................................................................................................
N-Ethyl-1-phenylcyclohexylamine ............................................................................................................................................
1-(1-Phenylcyclohexyl)pyrrolidine ............................................................................................................................................
1-[1-(2-Thienyl)cyclohexyl]piperidine .......................................................................................................................................
1-[1-(2-Thienyl)cyclohexyl]pyrrolidine ......................................................................................................................................
VerDate Sep<11>2014
18:12 Apr 20, 2021
Jkt 253001
PO 00000
Frm 00084
Fmt 4703
Sfmt 4703
E:\FR\FM\21APN1.SGM
21APN1
Schedule
7021
7023
7024
7025
7031
7032
7033
7034
7035
7036
7041
7042
7044
7047
I
I
I
I
I
I
I
I
I
I
I
I
I
I
7048
7049
7081
7083
7085
7089
I
I
I
I
I
I
7104
7118
7122
7144
7173
7200
7201
7203
7221
7222
7225
7245
7246
7249
7260
7297
7298
7315
7348
7350
7374
7381
7385
7390
7391
7392
7395
7396
7398
7399
7400
7401
7402
7404
7405
7411
7415
7431
7432
7433
7434
7435
7437
7438
7439
7443
7446
7455
7458
7470
7473
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
20736
Federal Register / Vol. 86, No. 75 / Wednesday, April 21, 2021 / Notices
Drug
code
khammond on DSKJM1Z7X2PROD with NOTICES
Controlled substance
N-Ethyl-3-piperidyl benzilate ....................................................................................................................................................
N-Methyl-3-piperidyl benzilate .................................................................................................................................................
N-Benzylpiperazine ..................................................................................................................................................................
4-MePPP (4-Methyl-alphapyrrolidinopropiophenone) .............................................................................................................
2C–D (2-(2,5-Dimethoxy-4-methylphenyl) ethanamine) ..........................................................................................................
2C–E (2-(2,5-Dimethoxy-4-ethylphenyl) ethanamine) .............................................................................................................
2C–H 2-(2,5-Dimethoxyphenyl) ethanamine) ..........................................................................................................................
2C–I 2-(4-iodo-2,5-dimethoxyphenyl) ethanamine) .................................................................................................................
2C–C 2-(4-Chloro-2,5-dimethoxyphenyl) ethanamine) ...........................................................................................................
2C–N (2-(2,5-Dimethoxy-4-nitro-phenyl) ethanamine) ............................................................................................................
2C–P (2-(2,5-Dimethoxy-4-(n)-propylphenyl) ethanamine) .....................................................................................................
2C–T–4 (2-(4-Isopropylthio)-2,5-dimethoxyphenyl) ethanamine) ............................................................................................
MDPV (3,4-Methylenedioxypyrovalerone) ...............................................................................................................................
25B–NBOMe (2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine) ............................................................
25C–NBOMe (2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine) ............................................................
25I–NBOMe (2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine) .................................................................
Methylone (3,4-Methylenedioxy-N-methylcathinone) ..............................................................................................................
Butylone ...................................................................................................................................................................................
Pentylone .................................................................................................................................................................................
N-Ethypentylone, ephylone (1-(1,3-benzodioxol-5-yl)-2-(ethylamino)-pentan-1-one) .............................................................
Alpha-pyrrolidinohexanophenone (a-PHP) ..............................................................................................................................
alpha-pyrrolidinopentiophenone (a-PVP) ................................................................................................................................
alpha-pyrrolidinobutiophenone (a-PBP) ..................................................................................................................................
Ethylone ...................................................................................................................................................................................
Alpha-pyrrolidinoheptaphenone (PV8) ....................................................................................................................................
AM–694 (1-(5-Fluoropentyl)-3-(2-iodobenzoyl) indole) ...........................................................................................................
Acetyldihydrocodeine ...............................................................................................................................................................
Benzylmorphine .......................................................................................................................................................................
Codeine-N-oxide ......................................................................................................................................................................
Cyprenorphine .........................................................................................................................................................................
Desomorphine .........................................................................................................................................................................
Etorphine (except HCl) ............................................................................................................................................................
Codeine methylbromide ...........................................................................................................................................................
Brorphine (1-(1-(1-(4-bromophenyl)ethyl)piperidin-4-yl)-1,3-dihydro-2H-benzo[d]imidazol-2-one) .........................................
Dihydromorphine .....................................................................................................................................................................
Difenoxin ..................................................................................................................................................................................
Heroin ......................................................................................................................................................................................
Hydromorphinol .......................................................................................................................................................................
Methyldesorphine ....................................................................................................................................................................
Methyldihydromorphine ...........................................................................................................................................................
Morphine methylbromide .........................................................................................................................................................
Morphine methylsulfonate .......................................................................................................................................................
Morphine-N-oxide ....................................................................................................................................................................
Myrophine ................................................................................................................................................................................
Nicocodeine .............................................................................................................................................................................
Nicomorphine ...........................................................................................................................................................................
Normorphine ............................................................................................................................................................................
Pholcodine ...............................................................................................................................................................................
Thebacon .................................................................................................................................................................................
Acetorphine ..............................................................................................................................................................................
Drotebanol ...............................................................................................................................................................................
U–47700 (3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide) ......................................................................
AH–7921 (3,4-dichloro-N-[(1-dimethylamino)cyclohexylmethyl]benzamide)) ..........................................................................
MT–45 (1-cyclohexyl-4-(1,2-diphenylethyl)piperazine)) ..........................................................................................................
Acetylmethadol ........................................................................................................................................................................
Allylprodine ..............................................................................................................................................................................
Alphacetylmethadol except levo-alphacetylmethadol ..............................................................................................................
Alphameprodine .......................................................................................................................................................................
Alphamethadol .........................................................................................................................................................................
Benzethidine ............................................................................................................................................................................
Betacetylmethadol ...................................................................................................................................................................
Betameprodine ........................................................................................................................................................................
Betamethadol ...........................................................................................................................................................................
Betaprodine .............................................................................................................................................................................
Clonitazene ..............................................................................................................................................................................
Dextromoramide ......................................................................................................................................................................
Isotonitazene (N,N-diethyl-2-(2-(4 isopropoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)ethan-1-amine) .....................................
Diampromide ...........................................................................................................................................................................
Diethylthiambutene ..................................................................................................................................................................
Dimenoxadol ............................................................................................................................................................................
Dimepheptanol .........................................................................................................................................................................
Dimethylthiambutene ...............................................................................................................................................................
Dioxaphetyl butyrate ................................................................................................................................................................
VerDate Sep<11>2014
18:12 Apr 20, 2021
Jkt 253001
PO 00000
Frm 00085
Fmt 4703
Sfmt 4703
E:\FR\FM\21APN1.SGM
21APN1
7482
7484
7493
7498
7508
7509
7517
7518
7519
7521
7524
7532
7535
7536
7537
7538
7540
7541
7542
7543
7544
7545
7546
7547
7548
7694
9051
9052
9053
9054
9055
9056
9070
9098
9145
9168
9200
9301
9302
9304
9305
9306
9307
9308
9309
9312
9313
9314
9315
9319
9335
9547
9551
9560
9601
9602
9603
9604
9605
9606
9607
9608
9609
9611
9612
9613
9614
9615
9616
9617
9618
9619
9621
Schedule
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
20737
Federal Register / Vol. 86, No. 75 / Wednesday, April 21, 2021 / Notices
Drug
code
khammond on DSKJM1Z7X2PROD with NOTICES
Controlled substance
Dipipanone ...............................................................................................................................................................................
Ethylmethylthiambutene ..........................................................................................................................................................
Etonitazene ..............................................................................................................................................................................
Etoxeridine ...............................................................................................................................................................................
Furethidine ...............................................................................................................................................................................
Hydroxypethidine .....................................................................................................................................................................
Ketobemidone ..........................................................................................................................................................................
Levomoramide .........................................................................................................................................................................
Levophenacylmorphan ............................................................................................................................................................
Morpheridine ............................................................................................................................................................................
Noracymethadol .......................................................................................................................................................................
Norlevorphanol ........................................................................................................................................................................
Normethadone .........................................................................................................................................................................
Norpipanone ............................................................................................................................................................................
Phenadoxone ...........................................................................................................................................................................
Phenampromide ......................................................................................................................................................................
Phenoperidine ..........................................................................................................................................................................
Piritramide ................................................................................................................................................................................
Proheptazine ............................................................................................................................................................................
Properidine ..............................................................................................................................................................................
Racemoramide ........................................................................................................................................................................
Trimeperidine ...........................................................................................................................................................................
Phenomorphan ........................................................................................................................................................................
Propiram ..................................................................................................................................................................................
1-Methyl-4-phenyl-4-propionoxypiperidine ..............................................................................................................................
1-(2-Phenylethyl)-4-phenyl-4-acetoxypiperidine ......................................................................................................................
Tilidine .....................................................................................................................................................................................
Acryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide) .........................................................................................
Para-Fluorofentanyl .................................................................................................................................................................
3-Methylfentanyl ......................................................................................................................................................................
Alpha-methylfentanyl ...............................................................................................................................................................
Acetyl-alpha-methylfentanyl .....................................................................................................................................................
N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)propionamide ...............................................................................................
Acetyl Fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide) .......................................................................................
Butyryl Fentanyl .......................................................................................................................................................................
Para-fluorobutyryl fentanyl .......................................................................................................................................................
4-Fluoroisobutyryl fentanyl (N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide) .................................................
2-methoxy-N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide .................................................................................................
Para-chloroisobutyryl fentanyl .................................................................................................................................................
Isobutyryl fentanyl ....................................................................................................................................................................
Beta-hydroxyfentanyl ...............................................................................................................................................................
Beta-hydroxy-3-methylfentanyl ................................................................................................................................................
Alpha-methylthiofentanyl .........................................................................................................................................................
3-Methylthiofentanyl .................................................................................................................................................................
Furanyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylfuran-2-carboxamide) .....................................................................
Thiofentanyl .............................................................................................................................................................................
Beta-hydroxythiofentanyl .........................................................................................................................................................
Para-methoxybutyryl fentanyl ..................................................................................................................................................
Ocfentanil .................................................................................................................................................................................
Valeryl fentanyl ........................................................................................................................................................................
N-(1-phenethylpiperidin-4-yl)-N-phenyltetrahydrofuran-2-carboxamide ..................................................................................
Crotonyl fentanyl ((E–N-(1-phenethylpiperidin-4-yl)-N-phenylbut-2-enamide) ........................................................................
Cyclopropyl Fentanyl ...............................................................................................................................................................
Cyclopentyl fentanyl ................................................................................................................................................................
Fentanyl related-compounds as defined in 21 CFR 1308.11(h) .............................................................................................
Phenmetrazine .........................................................................................................................................................................
Methylphenidate ......................................................................................................................................................................
Amobarbital ..............................................................................................................................................................................
Pentobarbital ............................................................................................................................................................................
Secobarbital .............................................................................................................................................................................
Glutethimide .............................................................................................................................................................................
Dronabinol in an oral solution in a drug product approved for marketing by the U.S. Food and Drug Administration .........
Nabilone ...................................................................................................................................................................................
1-Phenylcyclohexylamine ........................................................................................................................................................
Phencyclidine ...........................................................................................................................................................................
ANPP (4-Anilino-N-phenethyl-4-piperidine) .............................................................................................................................
Norfentanyl (N-phenyl-N-(piperidin-4-yl) propionamide) .........................................................................................................
Phenylacetone .........................................................................................................................................................................
1-Piperidinocyclohexanecarbonitrile ........................................................................................................................................
Alphaprodine ............................................................................................................................................................................
Anileridine ................................................................................................................................................................................
Coca Leaves ............................................................................................................................................................................
Cocaine ....................................................................................................................................................................................
VerDate Sep<11>2014
18:12 Apr 20, 2021
Jkt 253001
PO 00000
Frm 00086
Fmt 4703
Sfmt 4703
E:\FR\FM\21APN1.SGM
21APN1
9622
9623
9624
9625
9626
9627
9628
9629
9631
9632
9633
9634
9635
9636
9637
9638
9641
9642
9643
9644
9645
9646
9647
9649
9661
9663
9750
9811
9812
9813
9814
9815
9816
9821
9822
9823
9824
9825
9826
9827
9830
9831
9832
9833
9834
9835
9836
9837
9838
9840
9843
9844
9845
9847
9850
1631
1724
2125
2270
2315
2550
7365
7379
7460
7471
8333
8366
8501
8603
9010
9020
9040
9041
Schedule
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
20738
Federal Register / Vol. 86, No. 75 / Wednesday, April 21, 2021 / Notices
Drug
code
Controlled substance
Etorphine HCl ..........................................................................................................................................................................
Dihydrocodeine ........................................................................................................................................................................
Diphenoxylate ..........................................................................................................................................................................
Ecgonine ..................................................................................................................................................................................
Ethylmorphine ..........................................................................................................................................................................
Levomethorphan ......................................................................................................................................................................
Levorphanol .............................................................................................................................................................................
Isomethadone ..........................................................................................................................................................................
Meperidine ...............................................................................................................................................................................
Meperidine intermediate–A ......................................................................................................................................................
Meperidine intermediate–B ......................................................................................................................................................
Meperidine intermediate–C .....................................................................................................................................................
Metazocine ..............................................................................................................................................................................
Oliceridine (N-[(3-methoxythiophen-2yl)methyl] ({2-[9r)-9-(pyridin-2-yl)-6-oxaspiro [4.5]decan-9-yl]ethyl{time})amine fumarate).
Metopon ...................................................................................................................................................................................
Dextropropoxyphene, bulk (non-dosage forms) ......................................................................................................................
Dihydroetorphine .....................................................................................................................................................................
Opium tincture .........................................................................................................................................................................
Opium, powdered ....................................................................................................................................................................
Opium, granulated ...................................................................................................................................................................
Noroxymorphone .....................................................................................................................................................................
Phenazocine ............................................................................................................................................................................
Thiafentanil ..............................................................................................................................................................................
Piminodine ...............................................................................................................................................................................
Racemethorphan .....................................................................................................................................................................
Racemorphan ..........................................................................................................................................................................
Alfentanil ..................................................................................................................................................................................
Remifentanil .............................................................................................................................................................................
Sufentanil .................................................................................................................................................................................
Carfentanil ...............................................................................................................................................................................
Tapentadol ...............................................................................................................................................................................
Bezitramide ..............................................................................................................................................................................
Moramide-intermediate ............................................................................................................................................................
The company plans to import small
quantities of the listed controlled
substances for the National Institute on
Drug Abuse for research activities. The
company plans to import analytical
reference standards for distribution to
its customers for research and analytical
purposes.
Approval of permit applications will
occur only when the registrant’s
business activity is consistent with what
is authorized under 21 U.S.C. 952(a)(2).
Authorization will not extend to the
import of Food and Drug
Administration-approved or nonapproved finished dosage forms for
commercial sale.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2021–08166 Filed 4–20–21; 8:45 am]
khammond on DSKJM1Z7X2PROD with NOTICES
BILLING CODE P
VerDate Sep<11>2014
18:12 Apr 20, 2021
Jkt 253001
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–822]
Importer of Controlled Substances
Application: Scottsdale Research
Institute
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
Scottsdale Research Institute
has applied to be registered as an
importer of basic class(es) of controlled
substance(s). Refer to SUPPLEMENTAL
INFORMATION listed below for further
drug information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before May 21, 2021. Such persons
may also file a written request for a
hearing on the application on or before
May 21, 2021.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
SUMMARY:
PO 00000
Frm 00087
Fmt 4703
Sfmt 4703
Schedule
9059
9120
9170
9180
9190
9210
9220
9226
9230
9232
9233
9234
9240
9245
II
II
II
II
II
II
II
II
II
II
II
II
II
II
9260
9273
9334
9630
9639
9640
9668
9715
9729
9730
9732
9733
9737
9739
9740
9743
9780
9800
9802
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
22152. All requests for a hearing must
be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All requests for a
hearing should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/OALJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/DPW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In
accordance with 21 CFR 1301.34(a), this
is notice that on January 28, 2021,
Scottsdale Research Institute, 5436 East
Tapekim Road, Cave Creek, Arizona
85331, applied to be registered as an
importer of the following basic class(es)
of controlled substance(s):
Controlled substance
Marihuana ........................
Tetrahydrocannabinols ....
Psilocybin ........................
Psilocyn ...........................
Drug
code
Schedule
7360
7370
7437
7438
I
I
I
I
The company plans to import
Marijuana (7360) and
Tetrahydrocannabinols (7370) as
E:\FR\FM\21APN1.SGM
21APN1
]]>Agencies
[Federal Register Volume 86, Number 75 (Wednesday, April 21, 2021)]
[Notices]
[Pages 20734-20738]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-08166]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-816]
Importer of Controlled Substances Application: Research Triangle
Institute
AGENCY: Drug Enforcement Administration, Department of Justice.
ACTION: Notice of application.
-----------------------------------------------------------------------
SUMMARY: Research Triangle Institute has applied to be registered as an
importer of basic class(es) of controlled substance(s). Refer to
Supplementary Information listed below for further drug information.
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants therefore, may file written comments on or objections to
the issuance of the proposed registration on or before May 21, 2021.
Such persons may also file a written request for a hearing on the
application on or before May 21, 2021.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DPW,
8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a
hearing must be sent to: Drug Enforcement Administration, Attn:
Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All
requests for a hearing should also be sent to: (1) Drug Enforcement
Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive,
Springfield, Virginia 22152; and (2) Drug Enforcement Administration,
Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive,
Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this
is notice that on March 18, 2021, Research Triangle Institute, 3040
East Cornwallis Road, Hermann Building, Room 106, Research Triangle
Park, North Carolina 22709-0000, applied to be registered as an
importer of the following basic class(es) of controlled substance(s):
------------------------------------------------------------------------
Controlled substance Drug code Schedule
------------------------------------------------------------------------
3-Fluoro-N-methylcathinone (3-FMC).......... 1233 I
Cathinone................................... 1235 I
Methcathinone............................... 1237 I
4-Fluoro-N-methylcathinone (4-FMC).......... 1238 I
Pentedrone ([alpha]- 1246 I
methylaminovalerophenone).
Mephedrone (4-Methyl-N-methylcathinone)..... 1248 I
4-Methyl-N-ethylcathinone (4-MEC)........... 1249 I
Naphyrone................................... 1258 I
N-Ethylamphetamine.......................... 1475 I
N,N-Dimethylamphetamine..................... 1480 I
Fenethylline................................ 1503 I
Aminorex.................................... 1585 I
4-Methylaminorex (cis isomer)............... 1590 I
Gamma Hydroxybutyric Acid................... 2010 I
Methaqualone................................ 2565 I
Mecloqualone................................ 2572 I
JWH-250 (1-Pentyl-3-(2-methoxyphenylacetyl) 6250 I
indole).
SR-18 (Also known as RCS-8) (1- 7008 I
Cyclohexylethyl-3-(2-methoxyphenylacetyl)
indole).
ADB-FUBINACA (N-(1-amino-3,3-dimethyl-1- 7010 I
oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-
indazole-3-carboxamide).
5-Fluoro-UR-144 and XLR11 [1-(5-Fluoro- 7011 I
pentyl)1H-indol-3-yl](2,2,3,3-
tetramethylcyclopropyl)methanone.
AB-FUBINACA (N-(1-amino-3-methyl-1-oxobutan- 7012 I
2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-
carboxamide).
FUB-144 (1-(4-fluorobenzyl)-1H-indol-3- 7014 I
yl)(2,2,3,3-
tetramethylcyclopropyl)methanone).
JWH-019 (1-Hexyl-3-(1-naphthoyl)indole)..... 7019 I
MDMB-FUBINACA (Methyl 2-(1-(4-fluorobenzyl)- 7020 I
1H-indazole-3-carboxamido)-3,3-
dimethylbutanoate).
[[Page 20735]]
FUB-AMB, MMB- FUBINACA, AMB-FUBINACA (2-(1- 7021 I
(4-fluorobenzyl)-1Hindazole-3-carboxamido)-
3-methylbutanoate).
AB-PINACA (N-(1-amino-3-methyl-1-oxobutan-2- 7023 I
yl)-1-pentyl-1H-indazole-3-carboxamide).
THJ-2201 ([1-(5-fluoropentyl)-1H-indazol-3- 7024 I
yl](naphthalen-1-yl)methanone).
5F-AB-PINACA (N-(1-amino-3-methyl-1-oxobutan- 7025 I
2-yl)-1-(5-fluropentyl)-1H-indazole-3-
carboximide).
AB-CHMINACA (N-(1-amino-3-methyl-1-oxobutan- 7031 I
2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-
carboxamide).
MAB-CHMINACA (N-(1-amino-3,3dimethyl-1- 7032 I
oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-
indazole-3-carboxamide).
5F-AMB (Methyl 2-(1-(5-fluoropentyl)-1H- 7033 I
indazole-3-carboxamido)-3-methylbutanoate).
5F-ADB, 5F-MDMB-PINACA (Methyl 2-(1-(5- 7034 I
fluoropentyl)-1H-indazole-3-carboxamido)-
3,3-dimethylbutanoate).
ADB-PINACA (N-(1-amino-3,3-dimethyl-1- 7035 I
oxobutan-2-yl)-1-pentyl-1H-indazole-3-
carboxamide).
5F-EDMB-PINACA (ethyl 2-(1-(5-fluoropentyl)- 7036 I
1H-indazole-3-carboxamido)-3,3-
dimethylbutanoate).
5F-MDMB-PICA (methyl 2-(1-(5-fluoropentyl)- 7041 I
1H-indole-3-carboxamido)-3,3-
dimethylbutanoate).
MDMB-CHMICA, MMB-CHMINACA (Methyl 2-(1- 7042 I
(cyclohexylmethyl)-1H-indole-3-carboxamido)-
3,3-dimethylbutanoate).
MMB-CHMICA, AMB-CHMICA (methyl 2-(1- 7044 I
(cyclohexylmethyl)-1H-indole-3-carboxamido)-
3-methylbutanoate).
FUB-AKB48, FUB-APINACA, AKB48 N-(4- 7047 I
FLUOROBENZYL) (N-(adamantan-1-yl)-1-(4-
fluorobenzyl)-1H-indazole-3-carboximide).
APINACA and AKB48 (N-(1-Adamantyl)-1-pentyl- 7048 I
1H-indazole-3-carboxamide).
5F-APINACA, 5F-AKB48 (N-(adamantan-1-yl)-1- 7049 I
(5-fluoropentyl)-1H-indazole-3-carboxamide).
JWH-081 (1-Pentyl-3-(1-(4-methoxynaphthoyl) 7081 I
indole).
5F-CUMYL-PINACA, 5GT-25 (1-(5-fluoropentyl)- 7083 I
N-(2-phenylpropan-2-yl)-1H-indazole-3-
carboxamide).
5F-CUMYL-P7AICA (1-(5-fluoropentyl)-N-(2- 7085 I
phenylpropan-2-yl)-1H-pyrrolo[2,3-
b]pyridine-3-carboxamide).
4-CN-CUML-BUTINACA, 4-cyano-CUMYL-BUTINACA, 7089 I
4-CN-CUMYL BINACA, CUMYL-4CN-BINACA, SGT-78
(1-(4-cyanobutyl)-N-(2-phenylpropan-2-yl)-
1H-indazole-3-carboxamide).
SR-19 (Also known as RCS-4) (1-Pentyl-3-[(4- 7104 I
methoxy)-benzoyl] indole).
JWH-018 (also known as AM678) (1-Pentyl-3-(1- 7118 I
naphthoyl)indole).
JWH-122 (1-Pentyl-3-(4-methyl-1-naphthoyl) 7122 I
indole).
UR-144 (1-Pentyl-1H-indol-3-yl)(2,2,3,3- 7144 I
tetramethylcyclopropyl)methanone.
JWH-073 (1-Butyl-3-(1-naphthoyl)indole)..... 7173 I
JWH-200 (1-[2-(4-Morpholinyl)ethyl]-3-(1- 7200 I
naphthoyl)indole).
AM2201 (1-(5-Fluoropentyl)-3-(1-naphthoyl) 7201 I
indole).
JWH-203 (1-Pentyl-3-(2-chlorophenylacetyl) 7203 I
indole).
NM2201, CBL2201 (Naphthalen-1-yl 1-(5- 7221 I
fluoropentyl)-1H-indole-3-carboxylate.
PB-22 (Quinolin-8-yl 1-pentyl-1H-indole-3- 7222 I
carboxylate).
5F-PB-22 (Quinolin-8-yl 1-(5-fluoropentyl)- 7225 I
1H-indole-3-carboxylate).
4-Methyl-alpha-ethylaminopentiophenone (4- 7245 I
MEAP).
N-Ethylhexedrone............................ 7246 I
Alpha-ethyltryptamine....................... 7249 I
Ibogaine.................................... 7260 I
CP-47,497 (5-(1,1-Dimethylheptyl)-2-[(1R,3S)- 7297 I
3-hydroxycyclohexyl-phenol).
CP-47,497 C8 Homologue (5-(1,1- 7298 I
Dimethyloctyl)-2-[(1R,3S)3-
hydroxycyclohexyl-phenol).
Lysergic acid diethylamide.................. 7315 I
2C-T-7 (2,5-Dimethoxy-4-(n)- 7348 I
propylthiophenethylamine.
Marihuana Extract........................... 7350 I
Parahexyl................................... 7374 I
Mescaline................................... 7381 I
2C-T-2 (2-(4-Ethylthio-2,5-dimethoxyphenyl) 7385 I
ethanamine ).
3,4,5-Trimethoxyamphetamine................. 7390 I
4-Bromo-2,5-dimethoxyamphetamine............ 7391 I
4-Bromo-2,5-dimethoxyphenethylamine......... 7392 I
4-Methyl-2,5-dimethoxyamphetamine........... 7395 I
2,5-Dimethoxyamphetamine.................... 7396 I
JWH-398 (1-Pentyl-3-(4-chloro-1-naphthoyl) 7398 I
indole).
2,5-Dimethoxy-4-ethylamphetamine............ 7399 I
3,4-Methylenedioxyamphetamine............... 7400 I
5-Methoxy-3,4-methylenedioxyamphetamine..... 7401 I
N-Hydroxy-3,4-methylenedioxyamphetamine..... 7402 I
3,4-Methylenedioxy-N-ethylamphetamine....... 7404 I
3,4-Methylenedioxymethamphetamine........... 7405 I
4-Methoxyamphetamine........................ 7411 I
Peyote...................................... 7415 I
5-Methoxy-N-N-dimethyltryptamine............ 7431 I
Alpha-methyltryptamine...................... 7432 I
Bufotenine.................................. 7433 I
Diethyltryptamine........................... 7434 I
Dimethyltryptamine.......................... 7435 I
Psilocybin.................................. 7437 I
Psilocyn.................................... 7438 I
5-Methoxy-N,N-diisopropyltryptamine......... 7439 I
4-Chloro-alpha-pyrrolidinovalerophenone (4- 7443 I
chloro-a-PVP ).
4-Methyl-alpha-pyrrolidinohexiophenone 7446 I
(MPHP).
N-Ethyl-1-phenylcyclohexylamine............. 7455 I
1-(1-Phenylcyclohexyl)pyrrolidine........... 7458 I
1-[1-(2-Thienyl)cyclohexyl]piperidine....... 7470 I
1-[1-(2-Thienyl)cyclohexyl]pyrrolidine...... 7473 I
[[Page 20736]]
N-Ethyl-3-piperidyl benzilate............... 7482 I
N-Methyl-3-piperidyl benzilate.............. 7484 I
N-Benzylpiperazine.......................... 7493 I
4-MePPP (4-Methyl- 7498 I
alphapyrrolidinopropiophenone).
2C-D (2-(2,5-Dimethoxy-4-methylphenyl) 7508 I
ethanamine).
2C-E (2-(2,5-Dimethoxy-4-ethylphenyl) 7509 I
ethanamine).
2C-H 2-(2,5-Dimethoxyphenyl) ethanamine).... 7517 I
2C-I 2-(4-iodo-2,5-dimethoxyphenyl) 7518 I
ethanamine).
2C-C 2-(4-Chloro-2,5-dimethoxyphenyl) 7519 I
ethanamine).
2C-N (2-(2,5-Dimethoxy-4-nitro-phenyl) 7521 I
ethanamine).
2C-P (2-(2,5-Dimethoxy-4-(n)-propylphenyl) 7524 I
ethanamine).
2C-T-4 (2-(4-Isopropylthio)-2,5- 7532 I
dimethoxyphenyl) ethanamine).
MDPV (3,4-Methylenedioxypyrovalerone)....... 7535 I
25B-NBOMe (2-(4-bromo-2,5-dimethoxyphenyl)-N- 7536 I
(2-methoxybenzyl) ethanamine).
25C-NBOMe (2-(4-chloro-2,5-dimethoxyphenyl)- 7537 I
N-(2-methoxybenzyl) ethanamine).
25I-NBOMe (2-(4-iodo-2,5-dimethoxyphenyl)-N- 7538 I
(2-methoxybenzyl) ethanamine).
Methylone (3,4-Methylenedioxy-N- 7540 I
methylcathinone).
Butylone.................................... 7541 I
Pentylone................................... 7542 I
N-Ethypentylone, ephylone (1-(1,3- 7543 I
benzodioxol-5-yl)-2-(ethylamino)-pentan-1-
one).
Alpha-pyrrolidinohexanophenone (a-PHP)...... 7544 I
alpha-pyrrolidinopentiophenone ([alpha]-PVP) 7545 I
alpha-pyrrolidinobutiophenone ([alpha]-PBP). 7546 I
Ethylone.................................... 7547 I
Alpha-pyrrolidinoheptaphenone (PV8)......... 7548 I
AM-694 (1-(5-Fluoropentyl)-3-(2-iodobenzoyl) 7694 I
indole).
Acetyldihydrocodeine........................ 9051 I
Benzylmorphine.............................. 9052 I
Codeine-N-oxide............................. 9053 I
Cyprenorphine............................... 9054 I
Desomorphine................................ 9055 I
Etorphine (except HCl)...................... 9056 I
Codeine methylbromide....................... 9070 I
Brorphine (1-(1-(1-(4- 9098 I
bromophenyl)ethyl)piperidin-4-yl)-1,3-
dihydro-2H-benzo[d]imidazol-2-one).
Dihydromorphine............................. 9145 I
Difenoxin................................... 9168 I
Heroin...................................... 9200 I
Hydromorphinol.............................. 9301 I
Methyldesorphine............................ 9302 I
Methyldihydromorphine....................... 9304 I
Morphine methylbromide...................... 9305 I
Morphine methylsulfonate.................... 9306 I
Morphine-N-oxide............................ 9307 I
Myrophine................................... 9308 I
Nicocodeine................................. 9309 I
Nicomorphine................................ 9312 I
Normorphine................................. 9313 I
Pholcodine.................................. 9314 I
Thebacon.................................... 9315 I
Acetorphine................................. 9319 I
Drotebanol.................................. 9335 I
U-47700 (3,4-dichloro-N-[2- 9547 I
(dimethylamino)cyclohexyl]-N-
methylbenzamide).
AH-7921 (3,4-dichloro-N-[(1- 9551 I
dimethylamino)cyclohexylmethyl]benzamide)).
MT-45 (1-cyclohexyl-4-(1,2- 9560 I
diphenylethyl)piperazine)).
Acetylmethadol.............................. 9601 I
Allylprodine................................ 9602 I
Alphacetylmethadol except levo- 9603 I
alphacetylmethadol.
Alphameprodine.............................. 9604 I
Alphamethadol............................... 9605 I
Benzethidine................................ 9606 I
Betacetylmethadol........................... 9607 I
Betameprodine............................... 9608 I
Betamethadol................................ 9609 I
Betaprodine................................. 9611 I
Clonitazene................................. 9612 I
Dextromoramide.............................. 9613 I
Isotonitazene (N,N-diethyl-2-(2-(4 9614 I
isopropoxybenzyl)-5-nitro-1H-benzimidazol-1-
yl)ethan-1-amine).
Diampromide................................. 9615 I
Diethylthiambutene.......................... 9616 I
Dimenoxadol................................. 9617 I
Dimepheptanol............................... 9618 I
Dimethylthiambutene......................... 9619 I
Dioxaphetyl butyrate........................ 9621 I
[[Page 20737]]
Dipipanone.................................. 9622 I
Ethylmethylthiambutene...................... 9623 I
Etonitazene................................. 9624 I
Etoxeridine................................. 9625 I
Furethidine................................. 9626 I
Hydroxypethidine............................ 9627 I
Ketobemidone................................ 9628 I
Levomoramide................................ 9629 I
Levophenacylmorphan......................... 9631 I
Morpheridine................................ 9632 I
Noracymethadol.............................. 9633 I
Norlevorphanol.............................. 9634 I
Normethadone................................ 9635 I
Norpipanone................................. 9636 I
Phenadoxone................................. 9637 I
Phenampromide............................... 9638 I
Phenoperidine............................... 9641 I
Piritramide................................. 9642 I
Proheptazine................................ 9643 I
Properidine................................. 9644 I
Racemoramide................................ 9645 I
Trimeperidine............................... 9646 I
Phenomorphan................................ 9647 I
Propiram.................................... 9649 I
1-Methyl-4-phenyl-4-propionoxypiperidine.... 9661 I
1-(2-Phenylethyl)-4-phenyl-4- 9663 I
acetoxypiperidine.
Tilidine.................................... 9750 I
Acryl fentanyl (N-(1-phenethylpiperidin-4- 9811 I
yl)-N-phenylacrylamide).
Para-Fluorofentanyl......................... 9812 I
3-Methylfentanyl............................ 9813 I
Alpha-methylfentanyl........................ 9814 I
Acetyl-alpha-methylfentanyl................. 9815 I
N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4- 9816 I
yl)propionamide.
Acetyl Fentanyl (N-(1-phenethylpiperidin-4- 9821 I
yl)-N-phenylacetamide).
Butyryl Fentanyl............................ 9822 I
Para-fluorobutyryl fentanyl................. 9823 I
4-Fluoroisobutyryl fentanyl (N-(4- 9824 I
fluorophenyl)-N-(1-phenethylpiperidin-4-
yl)isobutyramide).
2-methoxy-N-(1-phenethylpiperidin-4-yl)-N- 9825 I
phenylacetamide.
Para-chloroisobutyryl fentanyl.............. 9826 I
Isobutyryl fentanyl......................... 9827 I
Beta-hydroxyfentanyl........................ 9830 I
Beta-hydroxy-3-methylfentanyl............... 9831 I
Alpha-methylthiofentanyl.................... 9832 I
3-Methylthiofentanyl........................ 9833 I
Furanyl fentanyl (N-(1-phenethylpiperidin-4- 9834 I
yl)-N-phenylfuran-2-carboxamide).
Thiofentanyl................................ 9835 I
Beta-hydroxythiofentanyl.................... 9836 I
Para-methoxybutyryl fentanyl................ 9837 I
Ocfentanil.................................. 9838 I
Valeryl fentanyl............................ 9840 I
N-(1-phenethylpiperidin-4-yl)-N- 9843 I
phenyltetrahydrofuran-2-carboxamide.
Crotonyl fentanyl ((E-N-(1- 9844 I
phenethylpiperidin-4-yl)-N-phenylbut-2-
enamide).
Cyclopropyl Fentanyl........................ 9845 I
Cyclopentyl fentanyl........................ 9847 I
Fentanyl related-compounds as defined in 21 9850 I
CFR 1308.11(h).
Phenmetrazine............................... 1631 II
Methylphenidate............................. 1724 II
Amobarbital................................. 2125 II
Pentobarbital............................... 2270 II
Secobarbital................................ 2315 II
Glutethimide................................ 2550 II
Dronabinol in an oral solution in a drug 7365 II
product approved for marketing by the U.S.
Food and Drug Administration.
Nabilone.................................... 7379 II
1-Phenylcyclohexylamine..................... 7460 II
Phencyclidine............................... 7471 II
ANPP (4-Anilino-N-phenethyl-4-piperidine)... 8333 II
Norfentanyl (N-phenyl-N-(piperidin-4-yl) 8366 II
propionamide).
Phenylacetone............................... 8501 II
1-Piperidinocyclohexanecarbonitrile......... 8603 II
Alphaprodine................................ 9010 II
Anileridine................................. 9020 II
Coca Leaves................................. 9040 II
Cocaine..................................... 9041 II
[[Page 20738]]
Etorphine HCl............................... 9059 II
Dihydrocodeine.............................. 9120 II
Diphenoxylate............................... 9170 II
Ecgonine.................................... 9180 II
Ethylmorphine............................... 9190 II
Levomethorphan.............................. 9210 II
Levorphanol................................. 9220 II
Isomethadone................................ 9226 II
Meperidine.................................. 9230 II
Meperidine intermediate-A................... 9232 II
Meperidine intermediate-B................... 9233 II
Meperidine intermediate-C................... 9234 II
Metazocine.................................. 9240 II
Oliceridine (N-[(3-methoxythiophen- 9245 II
2yl)methyl] ({2-[9r)-9-(pyridin-2-yl)-6-
oxaspiro [4.5]decan-9-yl]ethyl{time{time}
)amine fumarate).
Metopon..................................... 9260 II
Dextropropoxyphene, bulk (non-dosage forms). 9273 II
Dihydroetorphine............................ 9334 II
Opium tincture.............................. 9630 II
Opium, powdered............................. 9639 II
Opium, granulated........................... 9640 II
Noroxymorphone.............................. 9668 II
Phenazocine................................. 9715 II
Thiafentanil................................ 9729 II
Piminodine.................................. 9730 II
Racemethorphan.............................. 9732 II
Racemorphan................................. 9733 II
Alfentanil.................................. 9737 II
Remifentanil................................ 9739 II
Sufentanil.................................. 9740 II
Carfentanil................................. 9743 II
Tapentadol.................................. 9780 II
Bezitramide................................. 9800 II
Moramide-intermediate....................... 9802 II
------------------------------------------------------------------------
The company plans to import small quantities of the listed controlled
substances for the National Institute on Drug Abuse for research
activities. The company plans to import analytical reference standards
for distribution to its customers for research and analytical purposes.
Approval of permit applications will occur only when the
registrant's business activity is consistent with what is authorized
under 21 U.S.C. 952(a)(2). Authorization will not extend to the import
of Food and Drug Administration-approved or non-approved finished
dosage forms for commercial sale.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2021-08166 Filed 4-20-21; 8:45 am]
BILLING CODE P
